70
Participants
Start Date
October 31, 2016
Primary Completion Date
March 31, 2018
Study Completion Date
June 30, 2022
AmM MAGNITUDE Bioresorbable Drug-Eluting Coronary Scaffold
Placement of the investigational device into the diseased coronary artery to eliminate the vascular stenosis.
NOT_YET_RECRUITING
Clinica de Marly, Bogotá
RECRUITING
Instituto del Corazon, Bucaramanga
RECRUITING
EMMSA Clinica Especializada, Medellín
RECRUITING
Angiografia De Occidente S.A., Santiago de Cali
NOT_YET_RECRUITING
Azienda Policlinico-Vittorio Emanuele, Universita di Catania, Catania
NOT_YET_RECRUITING
Azienda Ospedaliero Universitaria Careggi, Florence
NOT_YET_RECRUITING
Azienda Ospedaliera Fatebenefratelli e Oftalmico, Milan
NOT_YET_RECRUITING
IRCCS Instituto Clinico Humanitas, Milan
NOT_YET_RECRUITING
Ospedale San Raffaele, Milan
NOT_YET_RECRUITING
Policlinico San Donato, Milan
NOT_YET_RECRUITING
A. O. U. Federico II˚ Policlinico, Napoli
NOT_YET_RECRUITING
Policlinico Universitario, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Padua
NOT_YET_RECRUITING
A. O. Ordine Mauriziano Umberto I, Torino
Lead Sponsor
Amaranth Medical Inc.
INDUSTRY